Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: Findings from the INTREPID clinical trial

British Journal of Ophthalmology

Volumn 103, Issue 4, 2019, Pages 469-474

  Freiberg, Florentina Joyce ^a   Michels, Stephan ^a,b   Muldrew, Alyson ^c   Slakter, Jason ^d   O'Shaughnessy, Denis ^e   Czeszynski, Alan ^f   Danielson, Linda ^g   Jackson, Timothy L ^h   Chakravarthy, Usha ^c  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^e Clinical Development   (United States)

^f Neurovision Imaging LLC   (United States)

^g INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

degeneration; macula; neovascularisation

Indexed keywords

VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MIDDLE AGED; MULTICENTER STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD VESSEL; RETINA FLUORESCEIN ANGIOGRAPHY; SAFETY; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; VISUAL IMPAIRMENT; WET MACULAR DEGENERATION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; MICROVASCULATURE; PATHOLOGY; RADIATION INJURY; RADIATION RESPONSE; RETROSPECTIVE STUDY; VISUAL ACUITY;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOUBLE-BLIND METHOD; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; RADIATION INJURIES; RETINAL VESSELS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 85049178928     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2018-311865     Document Type: Article

References (21)

1. Jackson TL, Chakravarthy U, Kaiser PK, et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study. Ophthalmology 2013;120:1893-900.
2. Jackson TL, Chakravarthy U, Slakter JS, et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study. Ophthalmology 2015;122:138-45.
3. Dugel PU, Bebchuk JD, Nau J, et al. Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET). Ophthalmology 2013;120:317-27.
4. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation retinopathy after externalbeam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994;30:765-73.
5. Archer DB, Gardiner TA. Ionizing radiation and the retina. Curr Opin Ophthalmol 1994;5:59-65.
6. Jackson TL, Danis RP, Goldbaum M, et al. Retinal vascular abnormalities in neovascular age-related macular degeneration. Retina 2014;34:568-75.
7. Hall EJ. Time, Dose and Fractionation in radiotherapy, Chapter 22 in Radiobiology for the Radiologist. 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2000:387-418.
8. Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008;18:234-9.
9. Chakravarthy U, Gardiner TA, Archer DB, et al. A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds. Curr Eye Res 1989;8:337-48.
10. Subhash HM, Leahy MJ. Microcirculation imaging based on full-range high-speed spectral domain correlation mapping optical coherence tomography. J Biomed Opt 2014;19:21103.
11. Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 2014;121:1435-44.
12. Archer DB. Doyne Lecture. Responses of retinal and choroidal vessels to ionising radiation. Eye 1993;7(Pt 1):1-13.
13. Hart PM, Chakravarthy U, Mackenzie G, et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 2002;120:1029-38.
14. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44.
15. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
16. Martin DF, Maguire MG, Fine SL, et al. . Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012;119:1388-98.
17. Chakravarthy U, Harding SP, Rogers CA, et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 2013;382:1258-67.
18. Amoaku WM, Archer DB. Fluorescein angiographic features, natural course and treatment of radiation retinopathy. Eye 1990;4 ( Pt 5:657-67.
19. Flickinger JC, Kondziolka D, Niranjan A, et al. Dose selection in stereotactic radiosurgery. Prog Neurol Surg 2007;20:28-42.
20. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-501.
21. Krebs IP, Krebs W, Merriam JC, et al. Radiation retinopathy: electron microscopy of retina and optic nerve. Histol Histopathol 1992;7:101-10.